Introduction
Revlixen 10 mg Capsule contains Lenalidomide, an immunomodulatory drug primarily used in the treatment of various hematological cancers. It is known for its potent anti-cancer, antiangiogenic, and immunomodulatory effects. Revlixen is manufactured by Everest Pharmaceuticals Ltd and is supplied globally by Onco Solution — your trusted oncology medicine partner.
Key Benefits
- Highly effective in treating multiple myeloma (MM) and myelodysplastic syndromes (MDS)
- Extends maintenance therapy for MM patients post-stem cell transplant
- Suitable for relapsed/refractory mantle cell lymphoma (MCL)
- Effective in combination therapy for follicular lymphoma (FL) and marginal zone lymphoma (MZL)
- Manufactured under stringent GMP compliance
Indications
Revlixen 10 mg is indicated for:
- Multiple Myeloma (MM): In combination with Dexamethasone or as maintenance therapy after autologous hematopoietic stem cell transplantation (auto-HSCT).
- Myelodysplastic Syndromes (MDS): For transfusion-dependent anemia associated with 5q cytogenetic abnormalities.
- Mantle Cell Lymphoma (MCL): For patients with relapsed or progressed disease after two prior therapies.
- Follicular Lymphoma (FL) & Marginal Zone Lymphoma (MZL): In combination with Rituximab for previously treated cases.
Dosage & Administration
Maintenance Therapy Post auto-HSCT:
- Start with 10 mg once daily on Days 1-28 in 28-day cycles.
- If tolerated, increase to 15 mg after 3 cycles.
For MDS:
- 10 mg daily until disease progression or toxicity.
Administration Guidelines:
- Swallow the capsule whole with water.
- Take at the same time daily, with or without food.
Pharmacology
Lenalidomide works by targeting cereblon, a protein in the ubiquitin ligase complex. This leads to degradation of transcription factors (Ikaros, Aiolos), modulating the immune response and exerting anti-tumor effects. It inhibits cancer cell proliferation, induces apoptosis, and enhances NK and T-cell activity. It also reduces inflammatory cytokines like TNF-α and IL-6.
Pharmacokinetics:
- Absorption: Rapid; peak plasma levels in 0.5–6 hours
- Distribution: ~30% plasma protein binding
- Metabolism: Minimal metabolism; largely excreted unchanged
- Elimination: Primarily renal; ~82% via urine within 24 hours
Drug Interactions
- Digoxin: May increase Digoxin levels; monitor plasma levels.
- Warfarin: No significant interactions observed, but monitor PT/INR.
- Thrombosis Risk: Use with caution alongside erythropoietic or estrogenic agents.
Contraindications
- Pregnancy: Causes severe fetal harm; contraindicated in pregnant females.
- Severe Hypersensitivity: Includes reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.
Side Effects
- Embryo-fetal toxicity
- Blood disorders: Neutropenia, thrombocytopenia
- Risk of thromboembolism (DVT, PE)
- Secondary malignancies
- Hepatotoxicity
- Severe skin reactions (SJS, TEN, DRESS)
- Tumor lysis syndrome
- Thyroid dysfunction
Special Populations
- Pediatrics: Not established for patients under 18 years
- Lactation: Unknown if excreted in breast milk. Avoid breastfeeding.
Precautions & Warnings
- REMS Program: Only available through Revlixen REMS for safety.
- Hematologic Monitoring: Frequent CBC tests required during treatment.
- Thromboprophylaxis: Recommended due to high VTE/ATE risks.
- Liver Monitoring: Monitor liver enzymes during therapy.
- Stem Cell Mobilization: Early referral for transplant planning is advised.
Overdose
There is no specific antidote for Lenalidomide overdose. Symptomatic management and supportive care are recommended.
Storage Conditions
- Store below 30°C
- Protect from moisture and light
- Keep out of reach of children
Manufacturer & Supplier Info
Manufacturer: Everest Pharmaceuticals Ltd
Global Supplier: Onco Solution – A Leading Worldwide Oncology Medicine Supplier
Conclusion
Revlixen 10 mg (Lenalidomide) Capsule is a proven, globally trusted oncology medication for treating hematologic malignancies. Onco Solution ensures consistent worldwide access to high-quality oncology treatments like Revlixen. Contact us for bulk supply or product queries.